The Jakarta Post

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
press enter to search

LOG IN / REGISTER
The Jakarta Post - Logo Mobile

Popular Reads

Much ado about asset forfeiture
Mass poisonings cast doubt on free meals reforms
New data rules could unlock cross-border data flows
Children are no longer the priority, were they ever?
Rescuers searching for 140 people from passenger ship in Java Sea

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

Popular Reads

Much ado about asset forfeiture
Mass poisonings cast doubt on free meals reforms
New data rules could unlock cross-border data flows
Children are no longer the priority, were they ever?
Rescuers searching for 140 people from passenger ship in Java Sea

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

therapy

AstraZeneca's antibody therapy prevents COVID-19, study shows
Health 5 years ago

AstraZeneca's antibody therapy prevents COVID-19, study shows

The company said on Friday that 75 percent of the participants in the trial for the therapy - two types of antibodies discovered by Vanderbilt University Medical Center - had chronic conditions including some with a lower immune response to vaccinations.
Arthritis drug shows promise against severe Covid: study
Health 5 years ago

Arthritis drug shows promise against severe Covid: study

Tofacitinib, taken orally and sold under the brand name Xeljanz among others, was tested in a trial of 289 patients hospitalized with severe Covid across 15 locations in Brazil.
Scents and sensibilities: The rise of Indonesia’s olfactory scene
Lifestyle 5 years ago

PREMIUM
Scents and sensibilities: The rise of Indonesia’s olfactory scene

What makes scents so intriguing to our emotions? The Jakarta Post spoke to several olfactory brands on what drives their exploration.
Open the windows to curb Covid spread: experts
Health 5 years ago

Open the windows to curb Covid spread: experts

Mounting evidence convinced many places to adopt mask-wearing recommendations and health authorities have for months said that crowded, badly ventilated indoor spaces are a particular risk. 
Scar tissue: Vietnamese women find healing with tattoos
Lifestyle 5 years ago

Scar tissue: Vietnamese women find healing with tattoos

Tattoo artist Ngoc inks middle-aged women whose lives have been upended by divorce or illness, each of them searching for healing through an art form that is still largely taboo in Vietnam.
US halts convalescent plasma trials for COVID-19 patients
Health 5 years ago

US halts convalescent plasma trials for COVID-19 patients

The trial that began in August involved just over 500 people who went to emergency rooms but did not need to be hospitalized.
Australia approves Pfizer vaccine for rollout in February
World 5 years ago

Australia approves Pfizer vaccine for rollout in February

The Therapeutic Goods Administration (TGA) granted provisional approval for the Pfizer product, making it the first Covid-19 vaccine to get the green light in Australia.
Germany to use Regeneron drugs touted by Trump
Health 5 years ago

Germany to use Regeneron drugs touted by Trump

"The government has bought 200,000 doses for 400 million euros ($486 million)," Spahn told the Bild am Sonntag newspaper, working out at 2,000 euros per dose.
Regeneron says its COVID-19 antibody therapy showed promise in patients
World 5 years ago

Regeneron says its COVID-19 antibody therapy showed promise in patients

The company is testing the therapy, a combination of two antibodies casirivimab and imdevimab, in hospitalized patients requiring low-flow oxygen.
US approves Regeneron antibody treatment given to Trump
World 5 years ago

US approves Regeneron antibody treatment given to Trump

The green light for drugmaker Regeneron came after REGEN-COV2, a combination of two lab-made antibodies, was shown to reduce Covid-19-related hospitalizations or emergency room visits in patients with underlying conditions.

Editor's Picks

Popular

The Jakarta Post
The Jakarta Post - Apps Store Icon The Jakarta Post - Google Play Icon

© 2016 - 2026 PT. Bina Media Tenggara

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.